Navigation Links
Diabetes For Dummies, 3rd Edition, Reports on the Latest Developments in the Field
Date:7/31/2008

tory, music to math, self-help to Spanish language, technology to travel, and more. The Dummies brand has expanded into new products and categories with language audio sets; and an extensive licensed product line, including art sets, craft kits, GPS navigation, fitness and hobby DVDs and more. For more information, visit Dummies.com. For Dummies is a branded imprint of Wiley.

###

Read the full story at http://www.prweb.com/releases/2008/07/prweb1156884.htm


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

1

GOOD

Page: 1 2 3 4

Related medicine news :

1. Innovative Diabetes Program in McLean County a Success
2. Pre-Pregnancy Diabetes Boosts Risk for Birth Defects
3. Childrens National Medical Center Program Director to Provide Expertise to DiabeTeens.com, The HealthCentral Networks Teen Diabetes Site
4. Broad Institute earns grant to support pathbreaking diabetes study
5. Toyota Tsusho America, Inc. and Nippon Kayaku Co., Ltd. Announce the Formation of GlycoMark, Inc., a Joint Venture to Develop and Commercialize Novel Biomarkers for Diabetes
6. Insight into mechanisms of diabetes-induced microvascular disease reveals new therapies
7. Diabetes could be a hidden condition for heart disease patients
8. Snapshots of eyes could serve as early warning of diabetes
9. Diabetes Online Health Guide Released on NHS Choices
10. Long Island, New York School Agrees To Admit Students With Diabetes
11. Diabetes, Weight Tied to Male Infertility

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Diabetes For Dummies, 3rd Edition, Reports on the Latest Developments in the Field
Diabetes For Dummies, 3rd Edition, Reports on the Latest Developments in the Field
(Date:11/25/2009)...,, TORONTOandCALGARY,Nov.25/PRNewswire/-Sentine...anceImaging(MRI)coilsandsoftwareandCalgaryScientif...ies,haveintroducedawebversionofAegis(TM)Breast4DAd...nterfaceisthefirsttrulyzero-footprintWebclientbase...ic,sPureWeb(TM)platformallowsforzero-footprintacce...
(Date:11/25/2009)...,, SILVERSPRING,Md.,Nov.25/PRNewswire-USNewswir...,sCenterforDrugEvaluationandResearch,titled"ADiffi...ppearsintheNov.26,2009issueofTheNewEnglandJournalo...-bin/prnh/20090824/FDALOGO ) ,, Inthearticle,Wo...cesstopainmedicationforthosewhoneeditandmanagingth...
(Date:11/25/2009)...,, BroadPoliticalEndorsements,Business,andPres...RNewswire-USNewswire/--Onceagain,theNationalBipola...amationendorsingtheir"Safe,tilStable"program,which...sureforbipolardisorder.Today,theNationalBipolarFou...lExpressPriorityMailfromtheLt.GovernorofLouisianaM...
(Date:11/25/2009)... A fortuitous discovery that grew out of a collab...d potentially offer hope to the nearly 10 million ...ase. , Also known as hardening of the arteri...on circulatory problem in which narrowed arteries ...onsidered a red flag for vascular disease, heart a...
(Date:11/25/2009)...tuximab, already used to fight rheumatoid arthriti...ds , , WEDNESDAY, Nov. 25 (HealthDay New...lymphoma and rheumatoid arthritis now also shows s...th type 1 diabetes. , The drug, rituximab (Ritu... own insulin, even though the disease had destroye...
Breaking Medicine News(10 mins):Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 3Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 2Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 3Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 3Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 4Health News:Type 1 Diabetes May Have a New Foe 2Health News:Type 1 Diabetes May Have a New Foe 3
...t it is all over between Kate Moss and Pete Dohert...ican model , it seems that the waifish beauty will...implant. The implant will be the fifth one... she understands that Doherty needs help and will ...
...ammed Haneef, the man from Bangalore in southern I...avy price for a small act of indiscretion, it look...his cousins, the key players in the failed Glasgow...ly to crash. First Australian authorities alm...
...that more than 90 per cent of women undergoing fer...f fertility drugs meant to stimulate their ovaries...ans that the drugs may not work properly, but also...however increased during IVF, by giving them drugs...
...ol of Public Health (HSPH) shows that patients who...ic quality measures have a lower chance of dying ... The researchers calculate that if the lowest p... surveyed hospitals from acute myocardial infarcti...
...ess' has been named the most vegan-friendly food c...d by the animal rights group for its cheese-free p...is one of the 20 organisations recognised by PETA ...London with a pizza oven and chef imported from It...
...started walking on two legs is something yet to be...sized that bipedalism evolved as a way of reducin... study to fully examine this theory among humans a...ll trials to analyze walking energetics and biomec...
Other Medicine News:Health News:Haneefs Visa Revoked by Australia 2Health News:Lower Mortality Rates in Hospitals With Good Quality Care 2
(Date:11/25/2009)...Nov.25/PRNewswire/--CempraPharmaceuticalsInc.today...fexecutiveofficer,willpresentatthePiperJaffray21st...2009,atTheNewYorkPalaceHotelinNewYorkCity.Dr.Ferna...ntibioticclinicalprogramsforthetreatmentofdrug-res...armaceuticals ,, Foundedin2006,CempraPharmaceu...
(Date:11/25/2009)...if.,Nov.25/PRNewswire/-- ChemoCentryx,Inc.,announ...sPROTECT-1(theProspectiveRandomizedOralTherapyEval...82-B)inpatientswithmoderate-to-severeCrohn,sdiseas...ndtolerabilityprofile.Thestudydemonstratedevidence...sdefinedasa70-pointdecreaseintheCrohn,sDiseaseActi...
(Date:11/24/2009)...ov.24/PRNewswire-FirstCall/--Vermillion,Inc.(VRML)...fReorganizationandDisclosureStatementtoday,Novembe...istrictofDelaware.AhearingtoconsiderapprovaloftheD...,2009,withthehearingontheconfirmationofthePlansche...panytopayallclaimsinfull.ThePlanisexpected,ifappro...
Breaking Medicine Technology:ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5Vermillion Files Plan of Reorganization 2Vermillion Files Plan of Reorganization 3Greenway Medical Technologies Enhances Advisory and Consulting Partnership Strategies with Regional Extension Centers 61548 1Greenway Medical Technologies Enhances Advisory and Consulting Partnership Strategies with Regional Extension Centers 61548 2Greenway Medical Technologies Enhances Advisory and Consulting Partnership Strategies with Regional Extension Centers 61548 3Greenway Medical Technologies Enhances Advisory and Consulting Partnership Strategies with Regional Extension Centers 61548 4Ultimat Vodka Joins Fight Against Hunger 61545 1Ultimat Vodka Joins Fight Against Hunger 61545 2Shopko Announces Launch of e Commerce Platform 61542 1Shopko Announces Launch of e Commerce Platform 61542 2
...HAYWARD, Calif., Aug. 6 Kosan Biosciences,Incorpo... Inc. has initiated,a Phase 1 clinical trial of mo...187, a selective and potent motilin receptor agoni...hageal reflux disease (GERD) and potentially,other...ical trial is,designed to test the safety, tolerab...
...SAN DIEGO, Aug. 7 Vical Incorporated (Nasdaq:,VIC...r ended June 30, 2007.,Revenues for the second qua...nues of $7.3 million for the second quarter of 200... $8.2 million, or $0.21 per share, compared,with a... the second quarter,of 2006. The increase in net l...
Other Medicine Technology:Kosan's Motilin Receptor Agonist, Licensed to Pfizer, Enters Phase 1 Clinical Trial in Gastroesophageal Reflux Disease 2Kosan's Motilin Receptor Agonist, Licensed to Pfizer, Enters Phase 1 Clinical Trial in Gastroesophageal Reflux Disease 3Kosan's Motilin Receptor Agonist, Licensed to Pfizer, Enters Phase 1 Clinical Trial in Gastroesophageal Reflux Disease 4Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs 2Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs 3Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs 4Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs 5Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs 6
Jeweler Type Bipolar Insulated Forceps
Robb Tonsil Knife
Canfield Tonsil Knife
Converse Button End Bistoury
Medicine Products: